Overview
Qingbo Liu practices practicing medicine in Shenyang, China.
Their clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Liver Cancer, and Hepatitis A.
They are actively involved in clinical research, co-authoring 38 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Qingbo Liu
Is Qingbo Liu a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Qingbo Liu is classified as an Experienced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Qingbo Liu participate in research or clinical trials?
Yes. Qingbo Liu has published 38 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Qingbo Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HepatitisLiu isExperienced. Learn about Hepatitis.
- Hepatitis ALiu isExperienced. Learn about Hepatitis A.
- Liver CancerLiu isExperienced. Learn about Liver Cancer.
- Lung CancerLiu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)